BRITTANY RENFROE: Open Payments
NPI 1346528536 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,170 in 87 payments from 16 companies in 2025. Trend: 2023 $1,569 · 2024 $1,264 · 2025 $2,170
Food & beverage: $1,990Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $318 |
| UCB, Inc. | 13 | $302 |
| Regeneron Healthcare Solutions, Inc. | 10 | $279 |
| GENZYME CORPORATION | 7 | $232 |
| SANOFI-AVENTIS U.S. LLC | 2 | $170 |
| Janssen Biotech, Inc. | 4 | $151 |
| E.R. Squibb & Sons, L.L.C. | 5 | $121 |
| Lilly USA, LLC | 4 | $114 |
| Amgen Inc. | 5 | $108 |
| Galderma Laboratories, L.P. | 5 | $100 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, RINVOQ, Sotyktu, TALTZ, Otezla.
Industry payments across GA — which companies pay providers there.
